Des experts internationaux évaluent de nouvelles données sur l’inhibition de l’aldostérone synthase dans la prise en charge de l’hypertension difficile à contrôler, à l’intention des professionnels de santé de premier recours
Migliorare la gestione dell’ipertensione di difficile controllo nell’assistenza primaria
Global Experts Evaluate New Data on Aldosterone Synthase Inhibition in the Management of Difficult-to-Control Hypertension for Primary Care Providers
Melhoria do manejo da hipertensão de difícil controle na Atenção Primária
Verbesserung des Managements schwer einstellbarer Hypertonie in der Primärversorgung
Mejora del manejo de la hipertensión de difícil control en Atención primaria
プライマリ・ケアにおける難治性高血圧管理の改善
The (Busy!) Year in Review: The Emergence of Aldosterone Synthase Inhibitors for Difficult-to-Control Hypertension in 2025
The (Busy!) Year in Review: The Emergence of Aldosterone Synthase Inhibitors for Difficult-to-Control Hypertension in 2025
The Nephrology Community’s Reception of New Phase 3 Data on Aldosterone Synthase Inhibitors for Difficult-to-Control Hypertension at ESC2025
The Nephrology Community’s Reception of New Phase 3 Data on Aldosterone Synthase Inhibitors for Difficult-to-Control Hypertension at ESC2025
New Phase 3 Data from ESC on Management of Uncontrolled or Treatment-Resistant Hypertension with an Aldosterone Synthase Inhibitor
New Phase 3 Data from ESC on Management of Uncontrolled or Treatment-Resistant Hypertension with an Aldosterone Synthase Inhibitor